Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 28, Issue 1-2, Pages 20-48Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/08830180802684331
Keywords
HIV vaccine; mucosal immunity; mucosal immunization; cellular and humoral responses
Categories
Funding
- Intramural Research Program of the National Institutes of Health, National Cancer Institute
- NATIONAL CANCER INSTITUTE [ZIABC011058, ZIABC011063, ZIABC011062, Z01BC005536] Funding Source: NIH RePORTER
Ask authors/readers for more resources
To date, most HIV vaccine strategies have focused on parenteral immunization and systemic immunity. These approaches have not yielded the efficacious HIV vaccine urgently needed to control the AIDS pandemic. As HIV is primarily mucosally transmitted, efforts are being re-focused on mucosal vaccine strategies, in spite of complexities of immune response induction and evaluation. Here, we outline issues in mucosal vaccine design and illustrate strategies with examples from the recent literature. Development of a successful HIV vaccine will require in-depth understanding of the mucosal immune system, knowledge that ultimately will benefit vaccine design for all mucosally transmitted infectious agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available